33 results on '"Khan, Irum"'
Search Results
2. Structural racism is a mediator of disparities in acute myeloid leukemia outcomes
3. Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia
4. 27 - Hematopoietic Cell Transplantation in Rare Hematologic Malignancies
5. Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative Neoplasms
6. Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease
7. Combination of Linear Accelerator–Based Intensity-Modulated Total Marrow Irradiation and Myeloablative Fludarabine/Busulfan: A Phase I Study
8. Measures of Structural Racism Predict ICU Admission Following Intensive Chemotherapy for AML
9. The antagonistic duality of NPM1 mutations in AML
10. List of Contributors
11. Individual-Level Social Determinants of Health (SDOH) Measures and Treatment Complications in Acute Leukemia
12. Impact of Socioeconomic Disparities on Outcomes in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
13. The Impact of Air Pollutants on a Chicagoland Cohort of Patients with Acute Myeloid Leukemia
14. Safety and Efficacy of the Addition of the Protein Translation Inhibitor Omacetaxine to Induction with Cytarabine and Idarubicin in Newly Diagnosed AML
15. A Mixed Methods Study to Examine the Influence of Structural Racism on Treatment in Acute Myeloid Leukemia
16. A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)
17. Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease
18. Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML
19. An Open-Label, Phase 2 Study of KRT-232, a First-in-Class, Oral Small Molecule Inhibitor of MDM2, for the Treatment of Patients with Myelofibrosis (MF) Who Have Previously Received Treatment with a JAK Inhibitor
20. Characteristics, Treatment Patterns and Outcomes Among Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Who Present with Hyperleukocytosis: Findings from a Large International Patient Cohort
21. Outcomes of Patients with Newly-Diagnosed Acute Myeloid Leukemia and Hyperleukocytosis Who Did Not Undergo Intensive Chemotherapy: Results from a Large International Database
22. Impact of Race on Outcomes in Intermediate Risk Acute Myeloid Leukemia
23. 52 - Non-Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease
24. A Single Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia
25. Validation of FOXM1 As a Therapeutic Target in Acute Myeloid Leukemia
26. 239 - A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy
27. 66 - Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/Refractory Multiple Myeloma: A Phase 1 Study
28. A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma
29. A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy
30. CCN2 - Exploring a New Biomarker in Myelofibrosis
31. FOXM1 Binds Nucleophosmin in AML and Confers Resistance to Chemotherapy
32. Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
33. Inhibition of AKT Signaling Potently Inhibits the Growth of JAK and MPL-Mutant Cells in the Myeloproliferative Neoplasms In Vitro and In Vivo,
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.